These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29869314)

  • 1. Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles.
    Silva J; Mendes M; Cova T; Sousa J; Pais A; Vitorino C
    AAPS PharmSciTech; 2018 Jul; 19(5):2383-2394. PubMed ID: 29869314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
    Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B
    Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
    Salunkhe SS; Bhatia NM; Bhatia MS
    Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
    Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
    Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
    Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
    Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC).
    Kovačević AB; Müller RH; Keck CM
    Int J Pharm; 2020 Feb; 576():118918. PubMed ID: 31870954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of miscibility and polymorphism of synthetic and natural lipids for nanostructured lipid carrier (NLC) formulations by Raman mapping and multivariate curve resolution (MCR).
    Mitsutake H; Ribeiro LNM; Rodrigues da Silva GH; Castro SR; de Paula E; Poppi RJ; Breitkreitz MC
    Eur J Pharm Sci; 2019 Jul; 135():51-59. PubMed ID: 31071439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicle-like structure of lipid-based nanoparticles as drug delivery system revealed by molecular dynamics simulations.
    Khalkhali M; Mohammadinejad S; Khoeini F; Rostamizadeh K
    Int J Pharm; 2019 Mar; 559():173-181. PubMed ID: 30684596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method.
    Kovács A; Berkó S; Csányi E; Csóka I
    Eur J Pharm Sci; 2017 Mar; 99():246-257. PubMed ID: 28012940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
    Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
    Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Lipid Nanoparticles (MLN), a New Generation of Lipid Nanoparticles for Drug Delivery Systems: Lamivudine-MLN Experimental Design.
    Cavalcanti SMT; Nunes C; Lima SAC; Soares-Sobrinho JL; Reis S
    Pharm Res; 2017 Jun; 34(6):1204-1216. PubMed ID: 28315084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.
    Cunha S; Costa CP; Loureiro JA; Alves J; Peixoto AF; Forbes B; Sousa Lobo JM; Silva AC
    Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
    Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
    Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured lipid carriers for site-specific drug delivery.
    Khosa A; Reddi S; Saha RN
    Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma.
    Shirazi AS; Varshochian R; Rezaei M; Ardakani YH; Dinarvand R
    J Mater Sci Mater Med; 2021 Jun; 32(7):78. PubMed ID: 34191134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.